AKT1 and gastric cancer: Studies have suggested that the tumorigenic function of CHI3L1 correlates with the aggressive behavior of tumor cells, which can be used as an independent molecular marker to predict poor prognosis in gastric cancer patients through activation of the AKT pathway [29,30].